383127-22-8 Usage
General Description
2-(4-Bromo-phenyl)-pyrrolidine is a chemical compound consisting of a pyrrolidine ring with a 4-bromo-phenyl group attached to it. It is often used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. 2-(4-BROMO-PHENYL)-PYRROLIDINE may have potential applications in the development of new drugs and research in the field of medicinal chemistry. It is important to handle 2-(4-Bromo-phenyl)-pyrrolidine with care, as it may have hazardous properties and should only be used by trained professionals in a controlled laboratory environment.
Check Digit Verification of cas no
The CAS Registry Mumber 383127-22-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,3,1,2 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 383127-22:
(8*3)+(7*8)+(6*3)+(5*1)+(4*2)+(3*7)+(2*2)+(1*2)=138
138 % 10 = 8
So 383127-22-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H12BrN/c11-9-5-3-8(4-6-9)10-2-1-7-12-10/h3-6,10,12H,1-2,7H2
383127-22-8Relevant articles and documents
INDOLO HEPTAMYL OXIME ANALOGUE AS PARP INHIBITOR
-
, (2021/12/15)
Disclosed is a type of indolo heptamyl oxime compounds as a PARP inhibitor. Specifically disclosed are a compound as represented by formula (II) and a pharmaceutically acceptable salt thereof.
PYRROLOPYRIMIDINE COMPOUNDS USED AS TLR7 AGONIST
-
, (2017/07/29)
The present invention relates to a pyrrolopyrimidine compound as TLR7 agonist, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation process thereof, a pharmaceutical composition containing such compounds and use thereof for manufacturing a medicament against viral infection.
METHODS OF USING DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY (ADP-RIBOSE)POLYMERASE (PARP)
-
, (2011/11/01)
Provided herein are methods of treating cancer comprising administering a topoisomerase inhibitor, temozolomide, or a platin in combination with a Compound of Formula (I) or Formula (II), where the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined herein.